<link rel="stylesheet" href="styles.f3b1fba60ec7970c.css">

Publication:
Evaluation of the prognostic role of absolute monocyte count, lymphocyte monocyte ratio and neutrophil lymphocyte ratio in hodgkin lymphoma: single center experience

Loading...
Thumbnail Image

Departments

Item type:Organizational Unit,
Item type:Organizational Unit,

School / College / Institute

Item type:Organizational Unit,
Item type:Organizational Unit,
SCHOOL OF MEDICINE
Upper Org Unit

Program

Organization Authors

Co-Authors

Date

Language

Embargo Status

NO

Journal Title

Journal ISSN

Volume Title

Alternative Title

Abstract

It is crucial to identify Hodgkin lymphoma (HL) patients who may have resistance to treatment in order to choose the best risk adapted strategy at the time of diagnosis. We evaluated whether AMC (Absolute monocyte count), ALC (Absolute lymphocyte count), Lym-phocyte/monocyte ratio (LMR), and Neutrophil Monocyte Ratio (NLR) were prognostic factors for HL. Sixty-five patients with classic Hodgkin Lymphoma were retrospectively reviewed. Initial peripheral blood tests were analyzed. Of the entire cohort, 96.9% (63) had complete or partial remission. The median overall survival was 144 and median progression free survival was 130.7 months. The median AMC and LMR for all patients were 0.8x103/UL and 2.1. There were no statistically significant cut-off value for AMC, ALC and LMR. Median NLR was 3.9 and had a statistically significant cut-off value as 4.38 (p= 0.002). Mean overall survival time with NLR &lt; 4.38 was 151.8 months versus 117.2 months for patients with &gt; 4.38 NLR (p= 0.047). Mean progression free survival time was also significantly longer for patients with NLR &lt; 4.38 versus &gt;4.38 (145.6 vs 102.8 months, p= 0.005). Increased NLR sound to be a poor prognostic indicator in our cohort. NLR might be considered an additive parameter in management decision tree.

Source

Publisher

Akademi Doktorlar Yayınevi

Subject

Citation

item.page.haspartof

Source

UHOD- International Journal of Hematology and Oncology / UHOD- Uluslararası Hematoloji Onkoloji Dergisi

item.page.ispartofseries

item.page.edition

DOI

10.4999/uhod.225586

item.page.datauri

item.page.link

Rights

Copyrights Note

Endorsement

Review

Supplemented By

Referenced By

Related Patent

Related Goal

Item type:Goal, Access status: Open Access ,
03 - Good Health and Well-being
Over the last 15 years, the number of childhood deaths has been cut in half. This proves that it is possible to win the fight against almost every disease. Still, we are spending an astonishing amount of money and resources on treating illnesses that are surprisingly easy to prevent. The new goal for worldwide Good Health promotes healthy lifestyles, preventive measures and modern, efficient healthcare for everyone.
Google Scholar
Scholar'da Ara ↗
Altmetric
Dimensions
PlumX Metrikleri
BIP! Indicators